But wait... There is more I left another thi

But wait...

There is more

I left another thing out...

When the management team had a lot of shares, that really prevented a takeover (i.e. poison bill of sorts). Now they don't. The bonus incentives would give them a bunch of shares,voting rights, etc. at the same time skyrocketing the share price. Win-Win.

But what if they don't hit those goals? We're screwed? Hostile takeover here we come?

Naw. Why put them in place if you didn't think you'd have a good shot of making them? You only would if you felt good about it. Of course anything can happen as we've learned but...

The company is trading at a market cap of $9.7M. Cash and short-term investments total $15.5M

"As of September 30, 2024, the Company had cash of $10,515 and short-term investments of $5,077."

To me, that translates into a 50% increase without even calculating in any potential revenue. So should the sp be $15 a share and then what would you add for 2024 revenue? 2025 projected revenue? Ask a financial advisor. They will probably tell you stocks are risky.

Quote:

---

Corporate Action, Change of Control, and Extraordinary Performance Agreements

As of the date of this Form 10-Q, the Company’s shares have traded and are continuing to trade at a price that results in a market cap that is significantly less than the Company’s current net cash position. Accordingly, the Company’s Board of Directors has determined that the Company is vulnerable to hostile takeover action and that any such action at this time is not in the best interests of its stockholders. The Company does not currently have any poison pill type provisions and due to previous reverse stock splits and other capital markets activities, the Company’s management and board members currently own an insignificant number of shares and as such would be ineffective in voting such shares to thwart any hostile takeover actions. Until such time as the Board determines whether it is necessary or advisable to adopt a poison pill provision or other anti-takeover measure, on October 31, 2024 the Board determined to approve the entry into Corporate Action, Change of Control, and Extraordinary Performance Agreements (the “Agreement”) with Rory J. Cutaia, Founder, Chairman and CEO of the Company, and James Geiskopf, Lead Director, (the “Awardees”) pursuant to which the Company will issue fully vested restricted stock units (“RSU”) subject to certain triggering events (the “Triggering Events”), as described below. Each RSU represents the right to be issued one share of common stock (the shares upon vesting, are subject to the restrictions as set forth in the Agreement, under the Company’s 2019 Omnibus Incentive Plan, or the RSU award agreement).

---